Articles tagged with Immune Response
Researchers at Karolinska Institutet discovered that B cells choose between cell fates to balance acute and memory responses. This understanding could optimize vaccines against viruses or other pathogens.
A Michigan Medicine study found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months. Nearly 90% of participants produced spike and nucleocapsid antibody responses, and all but one had persistent antibody levels at follow-up.
Researchers have identified the potential of 7HP349 as an oral medication to strengthen the effectiveness of vaccines, particularly for populations that struggle with immunosuppression. The study suggests adding 7HP349 to standard vaccination can improve vaccine efficacy without reformulating the vaccine.
Researchers at University of Illinois Chicago found a potential direct connection between neurodegenerative diseases, such as Alzheimer's disease, amyotrophic lateral sclerosis (ALS), glaucoma, and herpesvirus. The study suggests OPTN protein restricts HSV-1 virus spread in cells.
A study found that the ability to lose control over HIV is linked to a decrease in proliferative and cytolytic ability of immune cells, years before actual virus loss. In contrast to other infections, T cell dysfunction here impairs their response only to HIV.
A novel gene-based COVID-19 vaccine leveraging an adeno-associated viral vector platform was highly effective in eliciting neutralizing antibody responses and cellular immunity from a single dose. The vaccine provided near-complete protection against SARS-CoV-2 challenge in nonhuman primates for at least 11 months.
Researchers found that the gene TCF-1 regulates specific Treg cells, leading to more severe and inflammatory colon cancers. Without TCF-1, these cells become activated and gain a gut-homing feature, resulting in harsher cancer outcomes.
Researchers found that stressed fruit flies have the biggest change in their microbiome, suggesting a link between social stress, immunity, and longevity. The study used Drosophila melanogaster fruit flies and found sex- and age-specific variations in their microbiome composition.
Scientists are still unraveling how pathogens adapt to changing conditions, including climate change and global trade. Genome sequencing and big data technologies have revealed that dramatic events like hybridization between pathogen species can lead to rapid evolution of virulence on new host plants.
Researchers analyzed plasma and single immune cells from nearly 200 COVID-19 patients and found metabolic changes associated with disease severity. The study's findings could lead to better therapies targeting immune-metabolic changes in severe disease cases.
A UNSW psychology researcher recommends a set of neurocognitive and mental health questionnaires to harmonize the assessment of long COVID patients. These tests can be used internationally and in various cultural settings to address key questions about the problem, including brain fog and dementia risks.
A UC Riverside-led study identifies how loss-of-function mutations in the gene PTPN2 affect intestinal epithelial cells' ability to maintain a barrier. The researchers found that increased fluid loss and diarrhea are linked to the mutation, which can be reversed by treating cells with synthetic matriptase.
A new study from the University of Virginia Health System found that Moderna's vaccine produced higher antibody levels than Pfizer's, especially in older subjects. The researchers caution that measuring antibody levels does not necessarily predict vaccine effectiveness.
A study published in the American Journal of Transplantation found that Covid-19 vaccines stimulate different immune responses in organ transplant patients. While antibody tests alone are insufficient, combining vaccines with T cell analyses provides better protection.
A new study found that heat stress in pregnant dairy cows reduces fetal growth and influences the performance and immune development of offspring. Calves born to heat-stressed cows have lower birth weights, organ weights, and higher rates of cell death, suggesting compromised placental and fetal development.
A Rutgers study found that people with severe or prolonged COVID-19 have higher antibody levels against the virus. The study of 831 participants showed that immune responses vary by symptom severity, with those having persistent symptoms producing more antibodies.
A multidisciplinary team reveals two structural points in the Spike protein of SARS-CoV-2 that allow the virus to deceive the immune system. These mutations can be detected and inform strategies to control the pandemic.
Researchers uncover a neuro-immune process by which brain signals instruct immune function in visceral fat stores, providing new approaches for fighting obesity and related illness. The study identifies a critical mediator of neuro-immune communication, mesenchymal cells, and reveals the molecular messages exchanged across all steps.
Researchers assessed effectiveness of T-cell immune response to 11 SARS-CoV-2 variants, identifying HLA gene variants with significantly changed virus peptides. The T-cell COVID-19 Atlas portal (T-CoV) provides a comprehensive resource for understanding the impact of viral mutations on immunity.
Researchers found that some medications used to treat autoimmune rheumatic diseases can weaken the immune response to COVID-19 vaccines. Vaccination still induced an immune response in patients, but at a lower rate than in those without autoimmune diseases.
Flipon genetics proposes that evolution happens on a faster time scale than Darwin imagined, with rapid adaptations occurring in real-time within individuals. This is achieved through the simple sequence repeats of DNA, which can adopt alternative shapes and transmit adaptations to offspring.
A new research strategy enhances COVID-19 vaccine effectiveness by providing 'border protection' immunity in the nose, mouth and blood. The approach involves suppressing an enzyme that breaks down both pathogens and immune cells, resulting in a robust antibody response and improved protection against infections.
A study found that SARS-CoV-2 antibodies remained stable or increased in healthcare workers seven months after infection, indicating potential protection from pre-existing antibodies against common cold coronaviruses. The results suggest that individuals with higher levels of anti-HCoV IgG and IgA had lower susceptibility to COVID-19.
Immunocompromised individuals are at risk for prolonged viral shedding and the emergence of novel variants of concern. Healthcare providers must develop precise guidelines for monitoring and treating these patients.
Researchers have found a way to harness the power of immunotherapy for advanced prostate cancer by targeting a protein called PIKfyve. Blocking PIKfyve with the inhibitor ESK981 has been shown to increase tumor death and recruit immune T cells, offering new hope for patients with this challenging form of cancer.
A recent study from Scripps Research found that proof-of-concept HIV vaccines generate off-target antibodies that degrade the vaccine's payload, hindering protection. The research provides critical insights for improving HIV subunit trimer vaccines and offers a promising avenue for design improvements.
A study published in Nature Medicine found that combining different COVID-19 vaccines boosts the immune response by up to ten times. The research team discovered that a combination of AstraZeneca and BioNTech vaccines or double doses of BioNTech vaccination yields better results than a double dose of AstraZeneca vaccine.
Researchers define the atomic-level architecture of a protein-receptor connection that allows the malaria parasite to evade the immune response. A drug designed to fit into this space could block the interaction, allowing the immune system to clear away the pathogen and potentially reducing severe malaria cases.
Eija Kononen is a Professor and Chair of Periodontology at the University of Turku, Finland, known for her pioneering work on oral microbiology and its role in immune response. Her novel salivary diagnostic method, the Cumulative Risk Score, has been used in several studies to diagnose periodontal status.
Researchers at TMDU discovered a novel disorder resulting from a mutation in the AIOLOS protein, which causes immune deficiency and interferes with IKAROS protein function. The study found that the mutant protein forms a heterodimer with IKAROS, recruiting it to incorrect regions of the genome and leading to immunodeficiency.
A new study published in Science Translational Medicine reports on the protection offered by Ebola vaccines. The research found that different vaccine platforms conferred varying levels of protection, with RBD-specific antibodies and Fc-mediated immune functions playing key roles.
Australian scientists found that COVID-19 survivors produced sustained antibodies but they were less effective against contemporary variants. The study suggests vaccination is more effective than the body's natural response and highlights the need for new vaccine designs to keep pace with emerging variants.
Research from University of Johannesburg uncovers essential amino acids in wild African fruits. The study reveals several species exceed daily nutritional values recommended by WHO. The white olive and jacket plum are good candidates to boost immune function against viruses due to high lysine content.
A team of researchers has identified a mechanism explaining how Tpex cells can maintain their function for long periods, potentially improving the success rate of immunotherapy. The discovery was made by identifying increased amounts of an immunosuppressive molecule, which reduces activity of mTOR and dampens the immune response.
A new study by University of Miami researchers documents how coral genes respond to stony coral tissue loss disease, a rapidly spreading disease killing corals in Florida and the Caribbean. The study found that a network of genes important for cell death, immunity, and tissue rearrangement are triggered in response to the disease.
Recent evidence suggests diminished immune response to COVID-19 vaccines among immunosuppressed individuals. Researchers argue that developing targeted vaccination strategies is crucial to protect vulnerable populations and control new variant spread.
Researchers used machine learning to analyze tumor microenvironment and identify biomarkers that predict patient response to immunotherapy. The model outperformed current biomarkers, enabling personalized treatment and better understanding of biological mechanisms involved.
A new Finnish study found that healthcare workers who received two doses of the Pfizer-BioNTech vaccine had strong antibody responses to SARS-CoV-2, with similar effectiveness against the alpha variant as the original virus. The immune response was weaker against the beta variant, but still provided relatively good protection.
Scientists are using AI to investigate how gut bacteria interact with the human immune system, aiming to enhance vaccine response. They hope to find definitive cause-and-effect relationships between the microbiome and immune response.
A randomised controlled trial of 550 young people found two doses of CoronaVac to be safe and provoke a strong antibody response. Most adverse reactions were mild or moderate, with pain at the injection site being the most commonly reported symptom.
Researchers found that COVID-19 vaccines induce a robust and potentially long-lasting immune response with the formation of germinal centers in lymph nodes. Vaccination led to high levels of neutralizing antibodies effective against three variants of the virus, including the Beta variant from South Africa.
Researchers have developed two COVID-19 vaccines that elicited durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical research. The Moderna mRNA vaccine and a protein-based vaccine candidate showed strong immunity in infant rhesus macaques, with no adverse effects.
Researchers at Virginia Tech have identified a novel gene, Per2AS, that controls the sleep/wake cycle in mice, revealing the importance of non-coding genes in regulating biological processes. The study's findings could lead to breakthroughs in understanding internal body clocks and their role in various diseases.
A comprehensive review suggests that gut microbiota play a crucial role in immune responses to vaccinations. The study aims to improve vaccine effectiveness by understanding the microbiota's impact on B and T cell immune responses.
Researchers have discovered that non-professional cells can detect changes in metabolism and activate defensive measures against pathogens. This finding has implications for understanding immunity in humans and potentially developing new tools to prevent and treat infections.
Research finds that small chloroplasts in plant epidermal cells play a crucial role in controlling the entry of fungal pathogens. The study reveals that these chloroplasts migrate to the surface layer in response to fungal attacks, blocking their invasion into plant cells.
The vaccine has the potential to improve seasonal flu vaccine effectiveness, produce vaccines faster and use smaller doses. It achieved a strong immune response in mice, providing protection against two different strains of influenza.
A University of Queensland study has found that reduced levels of metabolic hormone leptin are associated with poor vaccine antibody responses in both young and older individuals. The research could lead to the development of new strategies for improving vaccine protection in vulnerable populations.
Researchers at the University of Vermont have discovered new biomarkers for predicting clinical and immune responses to dengue virus infection. These findings could aid in the development of more effective vaccines against all four dengue strains, a crucial step in combating this deadly disease.
A new study reveals key details of how SARS-CoV-2 variants escape the immune response created by natural infection or vaccination. The research highlights that several mutations are clustered in one site on the spike protein, disrupting antibody binding and neutralization.
Researchers developed a microparticle-based cancer vaccine that kickstarts an immune response, increasing the proportion of mice cured of tumors to 75%. Combining the vaccine with immune checkpoint inhibitors greatly improves treatment success, offering a promising approach to improving cancer treatment.
A University of Colorado Boulder study suggests that invertebrate immunity can prevent disease transmission, offering insights into COVID-19 and other zoonotic diseases. Researchers observed that some plankton can stop fungal spores from entering their bodies, while others clear infections within a limited window after exposure.
A large cohort study reveals that despite impaired immunity, dialysis patients maintain SARS-CoV-2 antibody levels for at least 6 months following infection. The researchers found no indication that subgroups with impaired immunity had a shorter-lived humoral response compared to healthy individuals.
Sperm deliver signals that increase the chances of conception by persuading female reproductive tissues to accept the male partner's genetic material. Factors like age, diet, and environmental exposures can affect sperm quality, impacting pregnancy health.
A novel screening strategy using cultured plant cells can identify microorganisms that stimulate plant immune mechanisms without harming plants. Eight bacterial strains were found to boost cryptogein-induced ROS production, inducing whole-plant resistance to bacterial pathogens.
Young zebra finches exposed to traffic noise developed songs with lower accuracy and were delayed in their vocal development. Chronic stress due to noise also suppressed the birds' immune function, leading to potential long-term health issues.
A dengue virus vaccine candidate has produced a protective immune response in infected mice, offering a promising alternative to existing vaccines. The UQ-developed vaccine uses an Australian insect virus and can be administered via a microarray patch for easy, needle-free delivery.
A new study found that five major kefir brands fell short of their claims, delivering between 10 million to 1 billion bacteria per gram. The researchers also identified discrepancies between the labeled species and those present in the products.
A study published in PLOS ONE found that participants who were touched by a humanoid robot during conversation reported a better emotional state. Those who received non-functional touch from the robot were more likely to comply with requests and exhibit positive behavioral responses, suggesting potential for robots to boost motivation.
Researchers developed an intranasal influenza vaccine using recombinant hemagglutinin and found it enhanced immune responses in mice. The vaccine showed superior immunoenhancing properties and conferred protection against both same and different virus strains.